Suppr超能文献

慢性肺病相关肺动脉高压(PH-CLD)的筛查与诊断:肺血管研究所创新药物开发倡议-3型肺动脉高压共识声明

Screening and diagnosis of pulmonary hypertension associated with chronic lung disease (PH-CLD): A consensus statement from the pulmonary vascular research institute's innovative drug development initiative-group 3 pulmonary hypertension.

作者信息

Vitulo P, Piccari L, Wort S J, Shlobin O A, Kovacs G, Vizza C D, Hassoun P M, Olschewski H, Girgis R E, Nikkho S M, Nathan S D

机构信息

Department of Pulmonary Medicine IRCCS Mediterranean Institute for Transplantation and Advanced Specialized, Therapies Palermo Sicilia Italy.

Department of Pulmonary Medicine Hospital del Mar, Pulmonary Hypertension Unit Barcelona Catalunya Spain.

出版信息

Pulm Circ. 2024 Dec 10;14(4):e70005. doi: 10.1002/pul2.70005. eCollection 2024 Oct.

Abstract

Pulmonary hypertension (PH) is a frequent complication of chronic lung disease (CLD). However, PH is difficult to diagnose early since accompanying symptoms overlap and are similar to those of the underlying CLD. In most cases the PH is mild to moderate and therefore physical signs may be absent or subtle. This consensus paper provides insight into the clues that might suggest the presence of occult PH in patients with CLD. An overview of current diagnostic tools and emerging diagnostic technologies is provided as well as guidance for the work-up and diagnosis of PH in patients with CLD.

摘要

肺动脉高压(PH)是慢性肺病(CLD)的常见并发症。然而,由于伴随症状重叠且与潜在的CLD症状相似,PH很难早期诊断。在大多数情况下,PH为轻度至中度,因此可能没有体征或体征不明显。本共识文件深入探讨了可能提示CLD患者存在隐匿性PH的线索。提供了当前诊断工具和新兴诊断技术的概述,以及CLD患者PH检查和诊断的指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/28d7/11629413/d2601890310d/PUL2-14-e70005-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验